• Faculty Members

Division of Gastroenterology

Smita Halder

MBChB, MRCP, MRes, Ph

Undergraduate Education

• University of Cambridge, UK, (BA, Medical Sciences, 1991)
• Edinburgh University, UK, (MBChB, 1994)

Postgraduate Training in Clinical Medicine and Gastroenterology

• Edinburgh Teaching hospitals (MRCP, 1997)
• Royal Victoria Infirmary, Newcastle
• Manchester Teaching hospitals
• MRC Research Fellowship 2002-6
• MRes (Health and Community, 2003) and PhD (2008) awarded from the University of Manchester. Title of PhD thesis: Unexplained gastrointestinal symptoms- Risk factors for onset and persistence.
• Mayo Clinic Rochester GI Research fellow: 2004-5
• CAG IBD Research Fellowship, Mount Sinai Hospital, Toronto: 2008-10

Research Interests

• Epidemiology of chronic GI disorders
• Use of biomarkers in determining GI disease course
• Clinical health outcomes in women with Inflammatory Bowel Disease

Selected Publications

1. Halder SLS, McBeth J, Silman AJ, Thompson DG, Macfarlane GJ. Psychosocial risk factors for the onset of abdominal pain. Results from a large prospective population-based study. International Journal of Epidemiology 2002; 31(6): 1219-1225.
2. Halder SLS, Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Alimentary Pharmacology & Therapeutics 2004; 19(2): 233-42.
3. Halder SLS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterology & Motility 2006; 18: 1001-1008.
4. O’Brien S, Halder SLS. GI Epidemiology: infection epidemiology and acute gastrointestinal infections. Alimentary Pharmacology & Therapeutics 2007; 25(6): 669-674.
5. Halder SLS, Locke GR, Schleck CD, Zinsmeister AR, Melton LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 15-year longitudinal population-based study. Gastroenterology 2007; 133: 799-807.
6. Halder SL, Talley NJ. Functional dyspepsia: A new Rome III paradigm. Current Treatment Options Gastroenterol. 2007; 10(4): 259-72.
7. Kabakchiev B, Halder SLS, Silverberg MS. Molecular Tests for Differential Diagnosis in Inflammatory Bowel Disease. Molecular Diagnosis & Therapy2009;13(4):217-23.
8. Halder SLS, Macfarlane GJ, Thompson DG, O'Brien SJ, Musleh M, McBeth J. Predictors of persistent gastrointestinal symptoms among new presenters to primary care. European Journal of Gastroenterology and Hepatology 2010; 22(3):296-305.